Today, the Research Advisory Panel of California (RAP-C) is sitting for the first time since last summer. While somewhat obscure, the panel is a key roadblock for studies primarily involving Schedule I or II controlled substances, or studies of addiction that employ any scheduled or non-scheduled medication. In recent years, many of the research projects that fit under the panel’s remit…
